In summary, our study elucidates a novel mechanism by which SMAD4 modulates NK cells in their response to CRC cells, suggesting that SMAD4 could serve as a promising target for NK cell therapy on CRC (Figure 7). Here, SMAD4 is linked to colorectal carcinoma.